Skip to main content
Press release October 29, 2026

Atomera Provides Third Quarter 2026 Results

Atomera Inc (ATOM)

October 29, 2026 , /PRNewswire/ -- ­­ Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the third quarter ended Sept. 30, 2026. Recent Company Highlights Increased engagement count to three customers in gate-all-around Signed a Joint Development Agreement with IQE to bring high-performance, cost-effective RF GaN to market Demonstrated simpler, lower cost approach to enable next-generation DRAM transistors with MST Management Commentary "This quarter we expanded our customer engagements in the advanced logic and memory segments, where AI continues to drive the need for higher transistor performance. Our ground-breaking nano-scale diffusion blocking work for gate-all-around transistors has generated interest not only with the GAA foundries, but also with designers of next generation memory solutions" said Scott Bibaud, president and CEO of Atomera. "While work in our traditional business is taking off, we also took an important step toward commercializing our GaN-on-silicon solutions by signing a joint development agreement with IQE, a leading supplier of compound semiconductor wafers." Financial Results The Company incurred a net loss of ($6.0) million, or ($0.15) per basic and diluted share in the third quarter of 2026, compared to a net loss of ($5.6) million, or ($0.17) per basic and diluted share, for the third quarter of 2025. Adjusted EBITDA (a non-GAAP financial measure) in the third quarter of 2026 was a loss of ($4.6) million compared to an adjusted EBITDA loss of ($4.4) million in the third quarter of 2025. The Company had $34.8 million in cash, cash equivalents and short-term investments as of Sept. 30, 2026, compared to $19.2 million as of December 31, 2025. The total number of shares outstanding was 39.1 million as of September 30, 2026. Third Quarter 2026 Results Webinar Atomera will host a live video webinar today to discuss its financial results and recent progress. Date: Thursday, Oct. 29, 2026 Time: 2:00 p.m. PT (5:00 p.m. ET) Webcast: Accessible at https://ir.atomera.com Note about Non-GAAP Financial Measures In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below. About Atomera Incorporated Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST ® ), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com. Safe Harbor This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-­looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues thus subjecting us to all the risks inherent in an early-stage enterprise; (2) the risk that licensees or JDA customers do not advance to royalty-based manufacturing and distribution licenses; (3) our ability to add other licensees and/or JDA customers; (4) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (5) our ability to protect our proprietary technology, trade secrets and know-­how and (6) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on February 24, 2026. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur. -- Financial Tables Follow – Atomera Incorporated Condensed Balance Sheets (in thousands, except per share data) September 30, December 31, 2026 2025 (Unaudited) ASSETS Current assets: Cash and cash equivalents $ 23,268 $ 19,210 Short-term investments 11,560 – Interest receivable 152 54 Prepaid expenses and other current assets 456 338 Total current assets 35,436 19,602 Property and equipment, net 62 60 Security deposit 14 14 Operating lease right-of-use asset 2,731 884 Financing lease right-of-use-asset 196 533 Total assets $ 38,439 $ 21,093 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 868 $ 608 Accrued expenses 522 168 Accrued payroll related expenses 1,326 650 Current operating lease liability 1,908 147 Current financing lease liability 198 420 Deferred Revenue – 7 Total current liabilities 4,822 2,000 Long-term operating lease liability 823 712 Total liabilities 5,645 2,712 Commitments and contingencies – – Stockholders' equity: – – Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding as of September 30, 2026 and December 31, 2025 Common stock: $0.001 par value, authorized 95,000 shares; 39,083 shares issued and outstanding as of September 30, 2026; and 32,354 shares issued and outstanding as of December 31, 2025 39 32 Additional paid in capital 292,874 260,043 Other comprehensive income (loss) (10) – Accumulated deficit (260,109) (241,694) Total stockholders' equity 32,794 18,381 Total liabilities and stockholders' equity $ 38,439 $ 21,093 Atomera Incorporated Condensed Statements of Operations (Unaudited) (in thousands, except per share data) Three Months Ended Nine Months Ended September 30, June 30, September 30, September 30, 2026 2026 2025 2026 2025 Revenue $ – $ 158 $ 11 $ 169 $ 15 Cost of revenue – (26) (128) (152) (190) Gross margin – 132 (117) 17 (175) Operating expenses Research and development 3,647 3,287 3,304 10,391 9,563 General and administrative 2,338 3,167 2,165 7,838 6,301 Selling and marketing 343 437 207 1,199 472 Total operating expenses 6,328 6,891 5,676 19,428 16,336 Loss from operations (6,328) (6,759) (5,793) (19,411) (16,511) Other income (expense) Interest income 254 172 232 623 736 Accretion income 75 178 – 310 6 Interest expense (7) (1) (12) (12) (51) Other income, net – 74 – 75 71 Total other income, net 322 423 220 996 762 Net loss $ (6,006) $ (6,336) $ (5,573) $ (18,415) $ (15,749) Net loss per common share, basic and diluted $ (0.15) $ (0.17) $ (0.17) $ (0.49) $ (0.51) Weighted average number of common shares outstanding, basic and diluted 38,899 38,647 31,128 37,614 30,593 Atomera Incorporated Reconciliation to Non-GAAP EBITDA (Unaudited) Three Months Ended Nine Months Ended September 30, June 30, September 30, September 30, 2026 2026 2025 2026 2025 Net loss (GAAP) $ (6,006) $ (6,336) $ (5,573) $ (18,415) $ (15,749) Depreciation and amortization 10 6 11 25 35 Stock-based compensation 1,746 1,741 1,342 4,893 3,629 Interest income (254) (172) (232) (623) (736) Accretion income (75) (178) – (310) (6) Interest expense 7 1 12 12 51 Other income, net – (74) – (75) (71) Net loss non-GAAP EBITDA $ (4,572) $ (5,012) $ (4,440) $ (14,493) $ (12,847) View original content to download multimedia:https://www.prnewswire.com/news-releases/atomera-provides-third-quarter-2026-results-302924164.html SOURCE Atomera Incorporated
View original release